Basket
Back to reports

DICE Therapeutics - Business Strategy Report

Powered by

All the data and insights you need on DICE Therapeutics in one report.

$295
Buy Report View Sample
DICE Therapeutics Business Strategy report

Published: March 18, 2023 Report Code: CMT3670718

Gain a 360-degree view of DICE Therapeutics and make more informed decisions for your business.

Our DICE Therapeutics Business Strategy Report is a valuable source of information for anyone involved in:

Business Development

  • Enhance your sales strategy and increase your chances of success
  • Understand DICE Therapeutics's position in the market and identify potential areas for collaboration
  • Stay ahead of your competitors with valuable insights on mergers and acquisitions (M&A) activity, capital raising, and alliances and partnerships including legal and financial adviser associations
  • Identify DICE Therapeutics's key executives

Competitive Intelligence

  • Gain a competitive edge in the industry
  • Understand DICE Therapeutics's strategic initiatives and identify opportunities for growth and investment
  • Get forward-looking insights from hiring trends, patenting activity, DICE Therapeutics's innovation landscape, social media strategy and brand perception
  • Support your decision-making with a management outlook on innovation, investments and IP risk exposure from earnings reports, investor presentations and ESG reports

Included in this Report:

  • What factors are shaping their future growth prospect?

    Access detailed overview of company’s SWOT analysis and financial performance to understand its strengths, weaknesses, opportunities, and threats

  • What is their approach to key business areas

    Gain a unique insight into company’s decision-making processes and how it compares with its peers

  • What is driving their success?

    Get a better understanding of company’s competitive landscape, potential growth opportunities, and overall market positioning

  • What is their potential future performance?

    Unlock a comprehensive ranking of companies based on their performance across 10 key industry themes

  • How are they leveraging digital technologies to drive growth?

    Get valuable insights into company’s approach to digital transformation and their plans for leveraging digital technologies to achieve their business goals

  • Who are they hiring?

    Stay informed on the latest developments in the company's talent acquisition strategy. Find out what skills and experience they are currently prioritising

  • What are their conversations and reputation in social media?

    Learn how the company is using digital technologies to engage with customers and drive brand awareness. Understand its online reputation and customer sentiment

  • What is their position in the market?

    Understand company’s position in the market and identify potential areas for collaboration

By purchasing the DICE Therapeutics Business Strategy Report you will access exclusive data from a trusted intelligence provider with decades of experience serving the most successful companies in the world.

Thousands of clients benefit from our trusted, actionable, and forward-looking intelligence every day. We help companies, government organisations and industry professionals profit from faster, more informed decisions.

DICE Therapeutics company overview and more information about the report

DICE Therapeutics Inc (DICE Therapeutics), formerly DiCE Molecules Holdings LLC, is a biopharmaceutical company that develops drugs for the treatment of immunological and chronic diseases. The company is investigating its lead product candidate IL-17 (interleukin 17), an immune-cell-derived cytokine to treat psoriasis and other IL-17 mediated chronic immune disorders and other indications. It is also evaluating drug candidates for the treatment of inflammatory bowel disease, fibrosis and other immune-oncology disorders. The company harnesses its proprietary DELSCAPE platform technology to identify selective oral small molecule antagonists to modulate protein-protein interactions (PPI) targets. DICE Therapeutics is headquartered in South San Francisco, California, the US.

Business Strategy

Unlock industry insights with our gold-standard data. Get an overview of DICE Therapeutics's strategies within its core industry. Understand the market trends shaping the industry to gain a deep understanding of DICE Therapeutics's strategic direction.

Financials and Ratios

Study DICE Therapeutics's history, mission, products/services, target market and competition. Understand how the company operates in its industry and analyse its health with key financial statements including revenue, expenses, assets, liabilities and cash flow

Deals

Get an overview of DICE Therapeutics's strategic plans with a geographical and thematic spread of M&A and investment strategy with corporate venturing and financial and legal adviser associations. Forward-looking Signals

CXO Insights

Insights from management, analyst sentiment and the divergence from earnings call transcripts. Furthermore, CXO priorities around investments, acquisitions, R&D, human capital, evolving risk exposures and geographic concerns help in understanding key strategic developments.

Competitive Benchmarking

Gain understanding on the DICE Therapeutics market positioning compared to its key peers . for a comparative analysis of all key signals including deals, patents, hiring and social media. Also . track strategic developments, financial performance across the DICE Therapeutics peers.

  • Company Profile
    • Key Facts
    • Company Financials
    • SWOT Analysis
    • Business Segments
    • Corporate Strategy
    • Key Executives
    • Industry Exposure
    • Locations & Subsidiaries
    Purchase to read more
  • Business Strategy
    • Top Selling Drugs
    • Drugs by Therapy Area
    • Drugs by Development Stage
    • Drugs by Therapy Area and Development Stage
    • Outsourcing Relationships
  • Theme Strategy
    • Theme Exposure
    • Valuation Scorecard
    • Risk Scorecard
  • Digital Landscape & Strategy
    • Technology Budget Estimates / ICT Budgets
    • ICT Contracts / Software & Services Contracts
    • Install Base
    • Recent Partnerships
  • Deal Strategy
    • M&A Strategy
    • Capital Raising Strategy
    • Strategic Alliances & Partnerships
    • Corporate Venturing
    • Advisor Strategy – Financial & Legal Advisors
  • Recent Developments
    • News Trend and Sentiment
    • Product Launches
    • Management Changes
    • Business Expansion
  • Management Outlook
    • Management vs. Analyst sentiment
    • Filings Sentiment and Mentions
    • CXO Intent ( R&D Investment, Human Capital)
    • Filing Theme Exposure
    • Mentions and Growth by Region
    • Location Exposure
    • Recent Filings
  • Social Media & Ad Strategy
    • Twitter Influencer Activity Trend
    • Reddit Activity Trend
  • Competitive Benchmarking
    • Key Facts
    • Financials
    • Financial Ratios
    • Deals Competitive Benchmarking
    • Patents Competitive Benchmarking
    • Hiring Activity Competitive Benchmarking
    • Social Media & Ads Competitive Benchmarking

DICE Therapeutics

DICE Therapeutics Business Strategy report
$295
Buy Report View Sample
Currency USD

About GlobalData

GlobalData is the trusted, gold standard intelligence provider to the world's largest industries.

We help thousands of companies, government organizations, and industry professionals profit from faster, more informed decisions.

Enquire Before Buying

Sample Report

DICE Therapeutics Business Strategy Report is the most comprehensive report available on the market and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at DICE Therapeutics in real time.

  • Access a live DICE Therapeutics dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more